Search results for: Pricing and Reimbursement

New research reveals, in carers’ own words, the multidimensional burden of caring for leukemia patients

20 November 2025

…and US, and 5 each from France, Germany, Italy and Spain – were asked questions about the patient’s diagnosis and how they became a carer, their experience of caregiving as…

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

2 June 2023

…consider i) pricing and reimbursement mechanisms, ii) standardising testing and care pathways, and iii) developing new infrastructure Share this: Download publication Next-generation sequencing (NGS) generates comprehensive and actionable information on…

Spotlight on OHE: Value Based Pricing and New Technologies

31 December 2012

…presentation (see below) discussed methods and processes for coordinating the assessment of diagnostics and treatments and urged that a consistent approach be developed and implemented. This was based in part…

Payment Models for Multi-Indication Therapies

1 November 2021

…Available from https://www.ohe.org/publications/multi-indication-pricing-mip-practical-solutions-and-steps-move-forward. Towse, A., Cole, A., and Zamora, B. (2018) The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. OHE Consulting Report. Available from https://www.ohe.org/publications/debate-indication-based-pricing-us-and-five-major-european-countries….

A global landscape analysis of access to tumour-agnostic therapies 

1 December 2025

…TA therapies – pembrolizumab, larotrectinib, and entrectinib – to assess regulatory, health technology assessment (HTA), and reimbursement outcomes and identify barriers and possible solutions along the access pathway. The key…

Privacy Policy

…to connect your computer to the internet, your login information, browser type and version, as well as browser plug-in type and versions, operating system and platform and if you access…

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

15 May 2023

…decisions. We discuss the next steps for enhancing the assessment and use of quality RWE in reimbursement decisions. RECOMMENDATIONS Several guidelines and frameworks have been produced and are welcomed, with…

Around the World in HTA: Japan – An algorithmic approach to containing costs

14 April 2026

…MFN could bring significant implications for the Japanese pharmaceutical market, potentially affecting pricing and access to innovative medicines, and the overall exposure of Japan’s system to global pricing pressures. Japan’s…

Careers at OHE

…working with UK-based or international organisations Understanding of health technology assessment (HTA), pharmaceutical pricing, and reimbursement issues Familiarity with academic and scientific communications Experience managing relationships with government officials and…